X4 Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
XFOR Nasdaq 2830 www.x4pharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders - Oct 9th, 2026 5:00 am
X4 Pharmaceuticals Secures Up to $150 Million in New Debt Financing From K2 HealthVentures - Oct 8th, 2026 6:30 am
X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures - Oct 8th, 2026 5:00 am
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct 1st, 2026 2:30 pm
Down 25.4% in 4 Weeks, Here's Why X4 Pharmaceuticals (XFOR) Looks Ripe for a Turnaround - Sep 24th, 2026 6:35 am
X4 Pharmaceuticals (XFOR) Loses 20.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Sep 11th, 2026 7:35 am
X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference - Sep 9th, 2026 5:00 am
X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting - Sep 8th, 2026 5:00 am
X4 Pharmaceuticals (XFOR) Upgraded to Buy: Here's Why - Aug 11th, 2026 10:00 am
X4 Pharmaceuticals (XFOR) Reports Q2 Loss, Beats Revenue Estimates - Aug 6th, 2026 5:10 pm
X4 Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Aug 6th, 2026 2:15 pm
Sarepta Therapeutics (SRPT) Q2 Earnings and Revenues Surpass Estimates - Aug 5th, 2026 6:35 pm
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jul 7th, 2026 2:30 pm
X4 Pharmaceuticals Appoints Kelly Gold, Experienced Chief Financial Officer, to its Board of Directors - Jul 1st, 2026 5:00 am
X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference - May 27th, 2026 5:00 am
How The X4 Pharmaceuticals (XFOR) Story Is Shifting With Mavorixafor And New EU Progress - May 20th, 2026 10:33 pm